Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
AtriCure Inc. (ATRC) PT Lowered to $49 at Canaccord Genuity
-
AtriCure to Participate at Upcoming Investor Conferences
-
AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast
-
AtriCure to Participate in Upcoming Investor Conferences
-
AtriCure to Participate at Upcoming Investor Conferences
-
AtriCure to Participate in Upcoming Investor Conferences
-
AtriCure to Participate at Upcoming Investor Conferences
-
AtriCure Inc. (ATRC) PT Raised to $53 at Canaccord Genuity
-
AtriCure (ATRC) Prices 3.98M Share Common Offering at $44/Sh
-
AtriCure Announces Pricing of Public Offering of Common Stock
-
AtriCure (ATRC) Announces Proposed $100M Share Common Offering
-
AtriCure Announces Proposed Public Offering of Common Stock
-
AtriCure to Participate in Upcoming Investor Conferences
-
AtriCure to Participate at the Canaccord Genuity 39th Annual Growth Conference
-
AtriCure to Participate in Upcoming Investor Conferences
-
AtriCure (ATRC) Prices 2.5M Shares Common Offering at $30.75/Sh
-
AtriCure Announces Pricing of Public Offering of Common Stock
-
AtriCure (ATRC) Announces Proposed 2.5M Share Common Offering
-
AtriCure Announces Proposed Public Offering of Common Stock
-
AtriCure to Present at the Canaccord Genuity 38th Annual Growth Conference
-
AtriCure Inc. (ATRC) PT Raised to $35 at Canaccord Genuity
-
AtriCure Inc. (ATRC) PT Raised to $27 at Canaccord Genuity
-
AtriCure Inc. (ATRC) PT Raised to $26 at Canaccord Genuity
-
AtriCure to Present at the Canaccord Genuity 37th Annual Growth Conference
-
AtriCure to Present at the Canaccord Genuity Growth Conference
-
Canaccord Genuity Sees Med-Tech M&A Accelerating
-
Canaccord Genuity Cuts Price Target on AtriCure (ATRC) on Current Weakness
-
Canaccord Genuity on AtriCure Inc. (ATRC): Bottom Line - Buy on Weakness
-
Canaccord Genuity Reiterates a 'Buy' on AtriCure Inc. (ATRC); Strong Hybrid Results
-
Canaccord Genuity Reiterates a 'Buy' on AtriCure Inc. (ATRC); Even Stronger Conviction After Meeting with CEO

